FDA extends review of Lantheus' LNTH-2501 imaging drug by three months

March 17, 2026 4:01 PM

Lantheus Holdings Inc. (NASDAQ: LNTH) announced the U.S. Food and Drug Administration has extended its review of the New Drug ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found